Background
Prostavive Research in Context: Understanding BPH
Benign prostatic hyperplasia (BPH), the non-cancerous prostate enlargement that most Prostavive ingredients target, is extremely common with age — histological evidence of BPH is found in roughly 90% of men by age 80, making it one of the most universal conditions of male aging rather than a rare disorder.
Standard medical treatment for symptomatic BPH includes alpha-blockers (which relax muscle around the bladder neck) and 5-alpha-reductase inhibitors (which reduce DHT production directly) — both proven in large clinical trials to reduce symptoms and, for the latter, shrink the prostate over time. Botanical and nutritional approaches like Prostavive are generally studied and used as complementary support alongside these treatments, not as a replacement for them, particularly once symptoms are moderate to severe.
The strongest-studied botanical for BPH symptoms remains saw palmetto, which Prostavive notably does not include — worth knowing if you've researched other prostate supplements and are comparing formulas.